Andrew, Paul V. http://orcid.org/0000-0002-9763-6413
Pinnock, Abigail
Poyner, Anna
Brown, Kirsty
Chittock, John http://orcid.org/0000-0002-1595-7441
Kay, Linda J.
Cork, Michael J. http://orcid.org/0000-0003-4428-2428
Danby, Simon G. http://orcid.org/0000-0001-7363-140X
Funding for this research was provided by:
Hyphens Pharma, Singapore
Article History
Received: 31 October 2023
Accepted: 6 December 2023
First Online: 4 January 2024
Declarations
:
: Simon G Danby, has received fees for giving lectures and/or attending advisory boards and research funding from Almirall, Astellas Pharma, Bayer Dermatology, Hyphens, Leo Pharma, L’Oreal, MSD, Pfizer, Rohto Pharma, Sanofi and Stiefel-GSK. Michael J Cork, has been/is a Clinical Trial Investigator for the following organisations: Atopix, Galapagos, Hyphens, Johnson & Johnson, Kymab, Leo, L’Oreal/La Roche Possay, Novartis, Pfizer, Regeneron, and Sanofi-Genzyme. He is an Advisory Board member, Consultant &/or invited lecturer for the following organisations: Abbvie, Amlar, Astellas, Atopix, Boots, Dermavant, Galapagos, Galderma, Hyphens, Johnson & Johnson, Kymab, Leo, L’Oreal/La Roche Possay, Menlo, Novartis, Oxagen, Pfizer, Procter & Gamble, Reckitt Benckiser, Regeneron, Sanofi-Genzyme. Paul V Andrew, Abigail Pinnock, Anna Poyner, Κirsty Βrown, John Chittock, Linda J K Kay declare that they have no competing interests.
: The University of Sheffield Research Ethics Committee approved the study, under the project reference 019255. It was performed in accordance with the Helsinki Declaration of 1964, and its later amendments, and all subjects provided informed consent to participate.